Hakan Akça
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- NF-κB Signaling Pathways
- MicroRNA in disease regulation
-
- PI3K/AKT/mTOR signaling in cancer
- Metabolism, Diabetes, and Cancer
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Cell death mechanisms and regulation 4
- Polyamine Metabolism and Applications 3
- Oncology 13
- Cytokine Signaling Pathways and Interactions 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Lindsey D. Mayo (3 shared papers)David B. Donner (3 shared papers)Jason A. Gustin (3 shared papers)Onur Tokgün (22 shared papers)Osman Nidai Özeş (1 shared paper)Tomohiko Maehama (1 shared paper)Jack E. Dixon (1 shared paper)Osman N. Özeş (8 shared papers)
- Journals
- Anti-Cancer Agents in Medicinal Chemistry (3 papers)Lung Cancer (3 papers)Biological Trace Element Research (2 papers)Gene (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (2 papers)
- Partner nations
- TürkiyeUnited StatesSpain
In The Last Decade
Hakan Akça
56 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 259
- Molecular Biology 610
- Oncology 208
- Biochemistry 41
- Immunology 113
Countries citing papers authored by Hakan Akça
This map shows the geographic impact of Hakan Akça's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Akça with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Akça more than expected).
Fields of papers citing papers by Hakan Akça
This network shows the impact of papers produced by Hakan Akça. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Akça. The network helps show where Hakan Akça may publish in the future.
Co-authors
The 25 scholars most cited alongside Hakan Akça, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 330 | |
| 2 | 2004 | 171 | |
| 3 | 2013 | 70 | |
| 4 | 2014 | 63 | |
| 5 | 2005 | 61 | |
| 6 | 2011 | 58 | |
| 7 | 2006 | 55 | |
| 8 | 2016 | 38 | |
| 9 | 2013 | 38 | |
| 10 | 2012 | 33 | |
| 11 | 2012 | 25 | |
| 12 | 2016 | 25 | |
| 13 | 2004 | 25 | |
| 14 | 2019 | 24 | |
| 15 | 2006 | 22 | |
| 16 | 2020 | 16 | |
| 17 | 2020 | 16 | |
| 18 | 2017 | 16 | |
| 19 | 2018 | 15 | |
| 20 | 2018 | 15 |
About Hakan Akça
Hakan Akça is a scholar working on Molecular Biology, Oncology, Cancer Research, Materials Chemistry and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Cell death mechanisms and regulation (4 papers), MicroRNA in disease regulation (4 papers), Porphyrin and Phthalocyanine Chemistry (3 papers), Polyamine Metabolism and Applications (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (259 citations), Molecular Biology (610 citations), Oncology (208 citations), Biochemistry (41 citations) and Immunology (113 citations). Hakan Akça has collaborated with scholars based in Türkiye, United States and Spain. Frequent co-authors include Lindsey D. Mayo, David B. Donner, Jason A. Gustin, Onur Tokgün, Osman Nidai Özeş, Tomohiko Maehama, Jack E. Dixon, Osman N. Özeş, Qiutang Li and Chandrashekhar K. Korgaonkar. Their work appears in journals such as Anti-Cancer Agents in Medicinal Chemistry, Lung Cancer, Biological Trace Element Research, Gene and Journal of Enzyme Inhibition and Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.